10 Hot Biotech Stocks Under $5 to Buy
On June 4, 2026, CNBC reported that global biopharma M&A is on track for its strongest year since the pre-pandemic peak seven years ago.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.08 | 1,529,402 | $19,999,989.95 | 1,529,402 | 2021-08-26 | Filing | |
| $13.08 | 259,998 | $3,399,993.85 | 259,998 | 2021-08-26 | Filing | |
| $13.08 | 1,529,402 | $19,999,989.95 | 1,529,402 | 2021-08-26 | Filing | |
| $0.81 | 5,000 | $4,073.50 | 453,019 | 2019-07-10 | Filing | |
| $0.90 | 5,000 | $4,485.00 | 448,019 | 2019-07-03 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.13 | 141,600 | $584,808.00 | 295,224 | 2026-04-16 | Filing | |
| $3.86 | 77,000 | $297,220.00 | 436,824 | 2026-04-15 | Filing | |
| $3.64 | 92,460 | $336,554.40 | 397,106 | 2026-04-14 | Filing | |
| $3.46 | 26,389 | $91,305.94 | 489,566 | 2026-04-13 | Filing | |
| $3.43 | 6,596 | $22,624.28 | 515,955 | 2026-04-10 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,922,828 | $8,806,552 | 0% | |
| 2. | 386,982 | $1,772,378 | 0% | |
| 3. | 82,632 | $378,455 | 0% | |
| 4. | 31,668 | $145,039 | 0% | |
| 5. | 24,363 | $111,583 | 0% |